This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

October 25-28, 2021
Delivered in a 100% Digital Format

Janet Lathey, Ph.D.
Health Science Specialist at DMID/NIAID/NIH


Janet Lathey, Ph.D., is a senior level virologist, immunologist, and translational scientist, specializing in vaccine development, measuring product effectiveness, and bioassay development. She is currently a Program Officer in the Vaccine Section of OBRRTR/DMID/NIAID/NIH.  Dr. Lathey has previously worked at Emergent BioSolutions on Anthrax vaccine development and measuring effectiveness. At Sanofi Pasteur as part of the clinical immunology group she was involved in the evaluation of influenza vaccines, and at ZYCOS she developed clinical assays for a therapeutic HPV vaccine. Before moving into vaccines, Dr. Lathey developed and standardized assays for HIV with the AIDS Clinical Trials Group.

Agenda Sessions

  • KEYNOTE: Standardizing Assays Using ZIKV as an Example

  • Live Q&A with Nadine Ritter and Janet Lathey